Scientists at the 2026 ACTRIMS forum meet to assess current approaches and explore new directions for MS research and care.

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...

Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...

People who are exposed to certain forever chemicals may be at greater risk of developing multiple sclerosis (MS), according ...

Scientists have uncovered two fresh sub-types of multiple sclerosis (MS) that could open doors to innovative treatments. Utilising artificial intelligence (AI), researchers examined brain scans ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational medicine ocrelizumab (OCREVUSTM ...

Multiple sclerosis may quietly damage the brain for years before symptoms appear, and scientists can now see it coming.

Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care. As the costs of multiple sclerosis (MS) treatments continue to rise, it is ...

SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 16, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and ...

Get all latest & breaking news on Multiple Sclerosis. Watch videos, top stories and articles on Multiple Sclerosis at moneycontrol.com.